Stephen Pastores, MD
Critical Care Medicine · New York, NYNPI 1366413502
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.6%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Biomerieux Inc at 52.3% of the total. Reporting peaked in 2021 at $9,105 and has fallen 72.3% since, to $2,519 in 2025. Among critical care medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 18 payments — averaging $967.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomerieux Inc$9K
- Portola Pharmaceuticals, LLC$3K
- BTG International Inc.$2K
- Fisher Scientific Company L.L.C.$2K
- La Jolla Pharmaceutical Company$218
- Medtronic$69
Across 2 payments — averaging $3602.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomerieux Inc$7K
- Amgen$161
What the payments were for
- Consulting fees$2,45014%
- Speaking & faculty fees$5,15930%
- Travel & lodging$8,81051%
- Food & beverage$9886%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomerieux Inc | 3 | $9,105 |
| Portola Pharmaceuticals, LLC | 8 | $3,379 |
| BTG International Inc. | 1 | $2,450 |
| Fisher Scientific Company L.L.C. | 3 | $2,185 |
| La Jolla Pharmaceutical Company | 2 | $218 |
| Medtronic | 1 | $69 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEPHROCHECK TEST$9,105
- ANDEXXA$3,250
- Procalcitonin$2,101
- GIAPREZA$218
How this compares
$17,406 in reported general payments places this provider in the 95th percentile of 442 critical care medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in New York
- Roxana SulicaNew York$211K
- Anna PodolanczukNew York$116K
- Jan BakkerNew York$49K
- Robert SladenNew York$40K
- Neil HalpernNew York$29K
- Singwu LawNew York$20K
- Peter SalgoNew York$18K
- Arvin ChinNew York$17K
- Nina PatelNew York$17K
- Jeremy BeitlerNew York$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.